bpc 157 ceretropic BPC-157 Vial BPC-157 | BPC 157 Peptide
Description
Ion Phys
50 , D316D325 (2022)
Effect sizes calculated in perprotocol primary efficacy analysis (which referred to outcome measures calculated after excluding weeks with deviations from target L-dopa oral dose) are reported in black
Weeks 5 through 8 increase to 5 mg weekly
10.3390/biomedicines9070792 42 KolovratM.GojkovicS.KrezicI.MalekinusicD.VrdoljakB.Kasnik KovacK.et al (2020)
Provides neuroprotective & cognitive support
